K984228

Substantially Equivalent

IS ANTI-TPO IGG ELISA TEST SYSTEM

Applicant: Columbia Bioscience, Inc.
Product code: JZO
Advisory panel: Immunology
Date received: 1998-11-25
Decision date: 1999-02-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Columbia, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.